After subjecting PC-3 prostate cancer cells to TPL treatment, we observed an upregulation in the mRNA expression levels of specific target genes (ADRB2, DAB2IP and CDKN2A) that are under negative regulation by EZH2. Here, EZH2 is linked to Familial prostate cancer.